Oakworth Capital’s iShares Biotechnology ETF IBB Stock Holding History

Oakworth Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$574K	Buy	3,018 +5	+0.2%	+$859	0.03%	140
2026 Q1	$509K	Hold	3,013	–	–	0.03%	140
2025 Q4	$509K	Hold	3,013	–	–	0.03%	133
2025 Q3	$435K	Buy	3,013 +13	+0.4%	+$1.77K	0.03%	149
2025 Q2	$380K	Hold	3,000	–	–	0.02%	146
2025 Q1	$384K	Hold	3,000	–	–	0.03%	141
2024 Q4	$397K	Hold	3,000	–	–	0.03%	141
2024 Q3	$437K	Hold	3,000	–	–	0.03%	129
2024 Q2	$412K	Hold	3,000	–	–	0.03%	129
2024 Q1	$412K	Hold	3,000	–	–	0.03%	132
2023 Q4	$408K	Buy	+3,000	New	+$366K	0.03%	135
2021 Q3	–	Sell	-1	Closed	–	–	582
2021 Q2	$0	Hold	1	–	–	﹤0.01%	596
2021 Q1	$0	Hold	1	–	–	﹤0.01%	589
2020 Q4	$0	Hold	1	–	–	﹤0.01%	583
2020 Q3	$0	Sell	1 -2	-67%	-$271	﹤0.01%	584
2020 Q2	$0	Sell	3 -54,009	-100%	-$6.88M	﹤0.01%	571
2020 Q1	$5.82M	Buy	54,012 +53,537	+11,271%	+$6.16M	1.37%	15
2019 Q4	$57K	Hold	475	–	–	0.01%	277
2019 Q3	$47K	Hold	475	–	–	0.01%	295
2019 Q2	$52K	Buy	475 +300	+171%	+$31.9K	0.01%	314
2019 Q1	$20K	Sell	175 -105	-38%	-$11.5K	﹤0.01%	390
2018 Q4	$27K	Hold	280	–	–	0.01%	352
2018 Q3	$34K	Hold	280	–	–	0.01%	338
2018 Q2	$31K	Hold	280	–	–	0.01%	346
2018 Q1	$29K	Buy	280 +207	+284%	+$22.9K	0.01%	327
2017 Q4	$23K	Buy	+73	New	+$7.8K	0.01%	371
2014 Q4	–	Sell	-81	Closed	-$7K	–	516
2014 Q3	$7K	Hold	81	–	–	﹤0.01%	308
2014 Q2	$7K	Hold	81	–	–	﹤0.01%	311
2014 Q1	$6K	Hold	81	–	–	﹤0.01%	316
2013 Q4	$6K	Buy	+81	New	+$5.75K	﹤0.01%	299

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Oakworth Capital's IBB Position: Q2 2026 in Review

Oakworth Capital increased its iShares Biotechnology ETF (IBB) stake by 0.17% in Q2 2026, buying an estimated $859 and bringing the position to 3,018 shares worth $574K. The position accounts for 0.03% of the portfolio, ranked #140.

Oakworth Capital first reported a position in IBB in Q4 2013 and has held it in 30 quarters since. The position peaked at $5.82M in Q1 2020. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Oakworth Capital held 3,018 shares of iShares Biotechnology ETF worth $574K as of Q2 2026.
Oakworth Capital bought 5 iShares Biotechnology ETF shares in Q2 2026, an estimated $859.
iShares Biotechnology ETF made up 0.03% of Oakworth Capital's portfolio in Q2 2026, its #140 holding.
Oakworth Capital first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 30 quarters since.
Oakworth Capital's iShares Biotechnology ETF position peaked at $5.82M in Q1 2020.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.